Cargando…
Lactobacillus crispatus BC1 Biosurfactant Delivered by Hyalurosomes: An Advanced Strategy to Counteract Candida Biofilm
The emergence of resistance to antifungal drugs has made the treatment of vulvovaginal candidiasis (VVC) very challenging. Among natural substances, biosurfactants (BS) produced by Lactobacillus have gained increasing interest in counteracting Candida infections for their proven anti-adhesive proper...
Autores principales: | Abruzzo, Angela, Giordani, Barbara, Parolin, Carola, De Gregorio, Priscilla R., Foschi, Claudio, Cerchiara, Teresa, Bigucci, Federica, Vitali, Beatrice, Luppi, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823809/ https://www.ncbi.nlm.nih.gov/pubmed/33401413 http://dx.doi.org/10.3390/antibiotics10010033 |
Ejemplares similares
-
Lactobacillus crispatus BC1 Biosurfactant Counteracts the Infectivity of Chlamydia trachomatis Elementary Bodies
por: Foschi, Claudio, et al.
Publicado: (2021) -
Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion
por: De Gregorio, Priscilla Romina, et al.
Publicado: (2020) -
Influence of Lactobacillus Biosurfactants on Skin Permeation of Hydrocortisone
por: Abruzzo, Angela, et al.
Publicado: (2021) -
Human Lactobacillus Biosurfactants as Natural Excipients for Nasal Drug Delivery of Hydrocortisone
por: Corazza, Elisa, et al.
Publicado: (2022) -
Anti-Candida Activity of Hyaluronic Acid Combined with Lactobacillus crispatus Lyophilised Supernatant: A New Antifungal Strategy
por: Parolin, Carola, et al.
Publicado: (2021)